SCHEMBL2207735

SCHEMBL2207735

O=C1OC(=O)c2cc(I)ccc21

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
CA12 O43570 4/20 0.50
CA7 P43166 4/20 0.50
ALDH1A1 P00352 1/20 0.48
TDP2 O95551 2/20 0.41
TGM2 P21980 1/20 0.41
CES1 P23141 1/20 0.41
CA1 P00915 3/20 0.39
CA4 P22748 2/20 0.39
CASP3 P42574 1/20 0.38
TYMS P04818 2/20 0.38
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
DAPK3 O43293 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24183992 0.77 TDP2 (0.40) ALOX15TDP1CA12CA7ALDH1A1
SCHEMBL29358248 0.75 ALOX15 (0.57) ALOX15TDP1CA12CA7ALDH1A1
SCHEMBL29359977 0.75 ALOX15 (0.57) ALOX15TDP1CA12CA7ALDH1A1
SCHEMBL741462 0.75 ALOX15 (0.57) ALOX15TDP1CA12CA7ALDH1A1
SCHEMBL29423347 0.75 ALOX15 (0.57) ALOX15TDP1CA12CA7ALDH1A1
SCHEMBL169305 0.75 ALOX15 (0.57) ALOX15TDP1CA12CA7ALDH1A1
SCHEMBL31409205 0.74 ALOX15 (0.48) ALOX15TDP1CA12CA7ALDH1A1
SCHEMBL11383281 0.74 ALOX15 (0.48) ALOX15TDP1CA12CA7ALDH1A1
SCHEMBL17192488 0.73 ALOX15 (0.55) ALOX15TDP1CA12CA7ALDH1A1
SCHEMBL15641977 0.73 ALOX15 (0.55) ALOX15TDP1CA12CA7ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117304149-A Synthesis method of 4-phenylacetylene phthalic anhydride 常州市尚科新材料有限公司 2023-12-29 CN claimed
CN-113813992-B Catalyst with magnetic separation nano particles grafted with NHPI, and preparation method and application thereof 江苏扬农化工集团有限公司 2023-11-28 CN claimed
CN-113813992-A Magnetic separation nanoparticle grafted NHPI catalyst and preparation method and application thereof 江苏扬农化工集团有限公司 2021-12-21 CN claimed
CN-110951076-B Hyperbranched polyetherimide and preparation and application thereof 北京化工大学 2020-12-11 CN claimed
CN-110951076-A Hyperbranched polyetherimide and preparation and application thereof 北京化工大学 2020-04-03 CN claimed
CN-101307004-B Polyfluorphenyl substituted aromatic diamine, polymers thereof and method for preparing same CHINESE ACAD INST CHEMISTRY 2011-08-31 CN claimed
CN-101307004-A Polyfluorphenyl substituted aromatic diamine, polymers thereof and method for preparing same CHINESE ACAD INST CHEMISTRY (CN) 2008-11-19 CN claimed
US-20260144748-A1 POLYOL-BASED MULTI-FUNCTIONAL COMPOUNDS FOR MEDICAL APPLICATIONS AND HYDROGELS FORMED FROM SAME BOSTON SCIENTIFIC SCIMED, INC. (US) 2026-05-28 US disclosed
WO-2026090380-A1 BIORESORBABLE CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS BOSTON SCIENTIFIC SCIMED, INC. (US) 2026-04-30 WO disclosed
US-20260115329-A1 BIORESORBABLE CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS BOSTON SCIENTIFIC SCIMED, INC. (US) 2026-04-30 US disclosed
EP-4730479-A2 FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME Kyoto University (JP) 2026-04-22 EP disclosed
US-20250249130-A1 RADIOPAQUE POLYPEPTIDES FOR INJECTABLE COMPOSITIONS BOSTON SCIENTIFIC SCIMED, INC. (US) 2025-08-07 US disclosed
US-20250246685-A1 FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME KYOTO UNIVERSITY (JP) 2025-07-31 US disclosed
EP-0530705-A1 Method for producing polyamide-imides EASTMAN KODAK COMPANY (US) 1993-03-10 EP disclosed
US-4960905-A CURING AGENT FOR EPOXY RESINS OCCIDENTAL CHEMICAL CORPORATION (US) 1990-10-02 US disclosed
US-4868316-A Process for the preparation of diether diphthalic anhydrides OCCIDENTAL CHEMICAL CORPORATION (US) 1989-09-19 US disclosed
US-4827000-A REACTION OF FLUOROPHTHALIC ANHYDRIDE WITH A PHENOL OCCIDENTAL CHEMICAL CORPORATION (US) 1989-05-02 US disclosed
EP-0308863-A2 Process for the preparation of phenoxy phthalic anhydrides OCCIDENTAL CHEMICAL CORPORATION (US) 1989-03-29 EP disclosed
EP-0288974-A2 Process for the preparation of diether diphthalic anhydrides OCCIDENTAL CHEMICAL CORPORATION (US) 1988-11-02 EP disclosed
US-4250007-A Photocurable acrylic phosphate esters of epoxidized polybutadiene UBE INDUSTRIES, LTD. (JP) 1981-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260115329-A1 BIORESORBABLE CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS RAD54L, EGFR, ARG1 ALOX15 2982/4885TDP1 1151/4885CA12 769/4885
US-20250249130-A1 RADIOPAQUE POLYPEPTIDES FOR INJECTABLE COMPOSITIONS IAPP, IGFBP6, NPPA ALOX15 4174/4885TDP1 2325/4885CA12 520/4885
US-20260144748-A1 POLYOL-BASED MULTI-FUNCTIONAL COMPOUNDS FOR MEDICAL APPLICATIONS AND HYDROGELS FORMED FROM SAME CD44, PAM, PLOD3 ALOX15 1626/4885TDP1 3513/4885CA12 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.